Advertisement

Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Organisation › Details

iTeos Therapeutics (Group)

iTeos is focused on expanding the benefits of immunotherapy for cancer patients by developing a proprietary pipeline targeting A2A, immune checkpoints and non-immunogenic (“cold”) tumors. It has licensed its IDO1 program, currently in Phase 1 development, to Pfizer. iTeos’ competitive edge is in the combination of expertise in drug discovery, translational tumor immunology and early clinical trial design. The company uses a unique platform to identify rational combinations of immunotherapies and novel targets. Based in Gosselies, Belgium, iTeos is a spin-off from the Ludwig Cancer Research (LICR) and de Duve Institute (UCL). The company is supported in part by the Walloon Region of Belgium and the FEDER (European Fund for Economic and Regional Development). *

 

Period Start 2012-05-25 splitoff before
  Predecessor Université Catholique de Louvain (UCL)
Product Industry cancer immunotherapy (immuno-oncology, I-O)
     
  Street 45 Rue Auguste Piccard
Biopark Incubator 2
  City 6041 Gosselies
    Address record changed: 2020-12-02
     
Basic data Employees B: 11 to 50 (2020-06-15)
  Currency USD
  Annual sales 4,779,000 (grant income + RnD tax credits (2019) 2019-12-31)
  Profit -22,454,000 (2019-12-31)
  Cash 21,988,000 (2019-12-31)
     
    * Document for �About Section�: iTeos Therapeutics S.A.. (7/28/17). "Press Release: iTeos Therapeutics Granted EUR 7.5 Million Non-Dilutive Funding by the Walloon Region". Gosselies.
     
   
Record changed: 2020-10-10

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group ChinaBio Partnerting Forum 2021 651x80




» top